Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by
5,000+ Wall Street analysts over the past 3-months

Name Upside % Analysts
bullish %
VIR icon
51
Vir Biotechnology
VIR
$667M
176%
upside
4 price targets
0
LXEO icon
52
Lexeo Therapeutics
LXEO
$289M
174%
upside
3 price targets
0
ENTA icon
53
Enanta Pharmaceuticals
ENTA
$161M
169%
upside
4 price targets
0
ARCT icon
54
Arcturus Therapeutics
ARCT
$490M
166%
upside
5 price targets
0
RARE icon
55
Ultragenyx Pharmaceutical
RARE
$2.77B
164%
upside
7 price targets
0
JANX icon
56
Janux Therapeutics
JANX
$1.41B
164%
upside
6 price targets
0
TYRA icon
57
Tyra Biosciences
TYRA
$648M
161%
upside
3 price targets
0
CRVO icon
58
CervoMed
CRVO
$67.8M
157%
upside
5 price targets
0
SLDB icon
59
Solid Biosciences
SLDB
$426M
156%
upside
4 price targets
0
AARD
60
Aardvark Therapeutics, Inc. Common Stock
AARD
$238M
155%
upside
3 price targets
0
IMNM icon
61
Immunome
IMNM
$783M
153%
upside
4 price targets
0
PROK icon
62
ProKidney
PROK
$342M
147%
upside
4 price targets
0
EVTL icon
63
Vertical Aerospace
EVTL
$468M
146%
upside
3 price targets
0
ANAB icon
64
AnaptysBio
ANAB
$554M
144%
upside
3 price targets
0
PRAX icon
65
Praxis Precision Medicines
PRAX
$927M
135%
upside
3 price targets
0
BBOT
66
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$855M
132%
upside
4 price targets
0
SVRA icon
67
Savara
SVRA
$622M
129%
upside
4 price targets
0
DYN icon
68
Dyne Therapeutics
DYN
$1.87B
125%
upside
9 price targets
0
AVBP icon
69
ArriVent BioPharma
AVBP
$710M
118%
upside
6 price targets
0
CCCC icon
70
C4 Therapeutics
CCCC
$241M
117%
upside
3 price targets
0
ARVN icon
71
Arvinas
ARVN
$559M
114%
upside
4 price targets
0
MVIS icon
72
Microvision
MVIS
$355M
112%
upside
3 price targets
0
LEGN icon
73
Legend Biotech
LEGN
$6.36B
109%
upside
6 price targets
0
NVCR icon
74
NovoCure
NVCR
$1.42B
106%
upside
3 price targets
0
GETY icon
75
Getty Images
GETY
$830M
106%
upside
3 price targets
0